β-Cell Proliferation, but not Neogenesis, Following 60% Partial Pancreatectomy is Impaired in the Absence of FoxM1
- Amanda Ackermann Misfeldt, B.S2,4,
- Robert H. Costa, PhD5 and
- Maureen Gannon, PhD (maureen.gannon{at}vanderbilt.edu)1,2,3,4
- 1Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
- 2Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
- 3Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
- 4Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
- 5Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois
Abstract
Objective: This study was designed to determine whether the transcription factor FoxM1 was required for regeneration of β-cell mass via proliferation and/or neogenesis in the adult after 60% partial pancreatectomy (PPx).
Research Design and Methods: Adult mice with a pancreas-wide deletion of Foxm1 (Foxm1flox/flox;Pdx1-Cre [FoxM1Δpanc]) and their Control littermates (Foxm1flox/flox) were subjected to PPx or a Sham operation, after which islet expression of Foxm1 and several target genes, β-cell mass, proliferation, β-cell size, islet size, islet density, and Neurogenin3 expression were analyzed.
Results: In Control mice, PPx stimulated β-cell proliferation and neogenesis and up-regulated Foxm1 and several of its known targets (Plk1, Cenp-a, Birc5/Survivin, Ccnb1) in islets. Within 1 week post-PPx, Control mice underwent significant regeneration of β-cell mass, and average islet size within the regenerating lobe was similar to that after a sham operation. However, FoxM1Δpanc mice exhibited specific impairments in β-cell mass regeneration and islet growth after PPx, with reduced proliferation of α and β-cells but no impairments in acinar or ductal cell proliferation. Interestingly, FoxM1 was not required for proliferation of β-cells within small endocrine cell clusters located in the regenerating portion of the pancreas, but was specifically required for proliferation of β-cells within larger islets. Additionally, FoxM1 was not required for β-cell neogenesis following PPx.
Conclusions: Our results indicate that FoxM1 is partially required for increased β-cell proliferation, but not β-cell neogenesis, stimulated by PPx. Furthermore, FoxM1 seems to be dispensable for proliferation of β-cells following neogenesis but is required for proliferation of pre-existing β-cells.
Footnotes
-
- Received July 1, 2008.
- Accepted August 15, 2008.
- Copyright © American Diabetes Association











